Evie Koslosky
Stock Analyst at Goldman Sachs
(3.48)
# 2,322
Out of 5,133 analysts
63
Total ratings
73%
Success rate
7.9%
Average return
Main Sectors:
Stocks Rated by Evie Koslosky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Reiterated: Hold | $1,510 → $1,640 | $1,738.91 | -5.69% | 5 | Nov 9, 2026 | |
| GH Guardant Health | Reiterated: Buy | $225 → $210 | $151.70 | +38.43% | 9 | Nov 6, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | $35 | $23.04 | +51.91% | 4 | Nov 5, 2026 | |
| GRAL GRAIL | Reiterated: Hold | $120 → $110 | $115.89 | -5.08% | 5 | Nov 5, 2026 | |
| NTRA Natera | Reiterated: Hold | $375 → $360 | $319.09 | +12.82% | 5 | Nov 5, 2026 | |
| BRKR Bruker | Reiterated: Sell | $50 → $55 | $61.59 | -10.70% | 7 | Nov 4, 2026 | |
| DHR Danaher | Rated: Buy | $250 → $275 | $233.02 | +18.02% | 7 | Oct 21, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | $780 → $830 | $700.22 | +18.53% | 3 | Oct 21, 2026 | |
| ADPT Adaptive Biotechnologies | Initiated Coverage: Buy | $35 | $29.04 | +20.52% | 1 | Sep 29, 2026 | |
| TEM Tempus AI | Initiated Coverage: Hold | $75 | $71.60 | +4.75% | 1 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 → $185 | $173.96 | +6.35% | 5 | Sep 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $100 → $140 | $154.39 | -9.32% | 3 | Sep 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $16.61 | +44.49% | 4 | Sep 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $425 → $515 | $460.25 | +11.90% | 4 | Sep 20, 2026 |
Mettler-Toledo International
Nov 9, 2026
Reiterated: Hold
Price Target: $1,510 → $1,640
Current: $1,738.91
Upside: -5.69%
Guardant Health
Nov 6, 2026
Reiterated: Buy
Price Target: $225 → $210
Current: $151.70
Upside: +38.43%
Caris Life Sciences
Nov 5, 2026
Reiterated: Buy
Price Target: $35
Current: $23.04
Upside: +51.91%
GRAIL
Nov 5, 2026
Reiterated: Hold
Price Target: $120 → $110
Current: $115.89
Upside: -5.08%
Natera
Nov 5, 2026
Reiterated: Hold
Price Target: $375 → $360
Current: $319.09
Upside: +12.82%
Bruker
Nov 4, 2026
Reiterated: Sell
Price Target: $50 → $55
Current: $61.59
Upside: -10.70%
Danaher
Oct 21, 2026
Rated: Buy
Price Target: $250 → $275
Current: $233.02
Upside: +18.02%
Thermo Fisher Scientific
Oct 21, 2026
Reiterated: Buy
Price Target: $780 → $830
Current: $700.22
Upside: +18.53%
Adaptive Biotechnologies
Sep 29, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $29.04
Upside: +20.52%
Tempus AI
Sep 22, 2026
Initiated Coverage: Hold
Price Target: $75
Current: $71.60
Upside: +4.75%
Sep 20, 2026
Reiterated: Buy
Price Target: $175 → $185
Current: $173.96
Upside: +6.35%
Sep 20, 2026
Reiterated: Hold
Price Target: $100 → $140
Current: $154.39
Upside: -9.32%
Sep 20, 2026
Reiterated: Buy
Price Target: $24
Current: $16.61
Upside: +44.49%
Sep 20, 2026
Rated: Buy
Price Target: $425 → $515
Current: $460.25
Upside: +11.90%